News

Life Science Factory to Open a New Location at Helmholtz Munich in 2024

© Helmholtz Munich / Matthias Tunger Photodesign

The Life Science Factory incubator initiated by Sartorius in Göttingen and the top biomedical research center Helmholtz Munich are entering into a strategic partnership to support spin-offs in the life sciences. Within this framework, the Life Science Factory will open a second location in the newly opened Helmholtz Pioneer Campus in spring 2024.

The new location will also offer young founders access to laboratories and essential infrastructure as well as authoritative business expertise and a start-up network in the field of life sciences, thus significantly supporting the translation of innovative technologies.

The opening of the Life Science Factory expands the services offered at the Pioneer Campus. The cooperation is intended to provide long-term and needs-based support for scientific spin-offs, both through optimal infrastructure and well-founded content-related support.

Life Science Factory occupies its own floor of about 1,800 m2 and provides fully equipped laboratories and co-working spaces to start-ups, which can also benefit from a wide-ranging mentoring and events program that offers opportunities for exchange and access to relevant start-up knowledge and a corresponding network. In terms of content, the offer focuses not only on life sciences but also on interface technologies such as bioengineering and AI applications.

Highly qualified, interdisciplinary researchers from all over the world work at the Helmholtz Pioneer Campus in Neuherberg. They connect for example artificial intelligence with biomedicine and engineering science with Helmholtz Munich's award-winning diabetes research, resulting in new cutting-edge technologies that stimulates important medical research.

The proximity to Helmholtz Munich and the resident research institutions is intended to promote greater exchange and the transfer of innovative research into commercial application. The unique environment is intended to stimulate researchers and founders to bring ideas into practice more quickly and easily, thus shaping the future of biomedical development.


Newsletter

Subscribe

Archive